These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 731121)
21. MBD children--variability in developmental patterns or growth inhibitory effect of stimulants? Kaffman M; Sher A; Bar-Sinai N Isr Ann Psychiatr Relat Discip; 1979 Mar; 17(1):58-66. PubMed ID: 287660 [No Abstract] [Full Text] [Related]
22. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health. Moungnoi P; Maipang P J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770 [TBL] [Abstract][Full Text] [Related]
23. The efficacy of stimulant drug treatment for hyperactivity: a meta-analysis. Kavale K J Learn Disabil; 1982 May; 15(5):280-9. PubMed ID: 6123539 [No Abstract] [Full Text] [Related]
24. Stimulant treatment over 5 years: effects on growth. Charach A; Figueroa M; Chen S; Ickowicz A; Schachar R J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):415-21. PubMed ID: 16601646 [TBL] [Abstract][Full Text] [Related]
25. One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. Quinn PO; Rapoport JL Am J Psychiatry; 1975 Mar; 132(3):241-5. PubMed ID: 1090193 [TBL] [Abstract][Full Text] [Related]
26. The growth of children given stimulant drugs. Nutr Rev; 1973 Mar; 31(3):91-2. PubMed ID: 4574834 [No Abstract] [Full Text] [Related]
27. Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children. Safer DJ; Allen RP J Pediatr; 1989 Dec; 115(6):1003-8. PubMed ID: 2585214 [TBL] [Abstract][Full Text] [Related]
28. Effect of long-term treatment with stimulant medication on growth? Poulton A J Am Acad Child Adolesc Psychiatry; 2007 Mar; 46(3):305. PubMed ID: 17314713 [No Abstract] [Full Text] [Related]
29. Ten years of experience with 1,000 hyperactive children in a private practice. Eichlseder W Pediatrics; 1985 Aug; 76(2):176-84. PubMed ID: 4022690 [TBL] [Abstract][Full Text] [Related]
30. Oral medications for minimal brain dysfunction in children. Green RP; Scales SM; Rosser PL J Natl Med Assoc; 1973 Mar; 65(2):157-60. PubMed ID: 4691677 [No Abstract] [Full Text] [Related]
31. Effect of methylphenidate hydrochloride on stature of hyperactive children. Kalachnik JE; Sprague RL; Sleator EK; Cohen MN; Ullmann RK Dev Med Child Neurol; 1982 Oct; 24(5):586-95. PubMed ID: 7141116 [TBL] [Abstract][Full Text] [Related]
32. Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment. Bereket A; Turan S; Karaman MG; Haklar G; Ozbay F; Yazgan MY Horm Res; 2005; 63(4):159-64. PubMed ID: 15795512 [TBL] [Abstract][Full Text] [Related]
33. Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome. Gross MD Psychosomatics; 1975; 16(1):26-7. PubMed ID: 1101283 [No Abstract] [Full Text] [Related]
34. Nocturnal levels of growth hormone in hyperactive children of small stature. Stahl ML; Orr WC; Griffiths WJ J Clin Psychiatry; 1979 May; 40(5):225-7. PubMed ID: 438145 [TBL] [Abstract][Full Text] [Related]
35. Growth rebound after termination of stimulant drugs. Safer DJ; Allen RP; Barr E J Pediatr; 1975 Jan; 86(1):113-6. PubMed ID: 1110433 [TBL] [Abstract][Full Text] [Related]